Search Results
77 results found with an empty search
- HPV Product Page | CDL
The product page for the HPV cervical cancer test at Clinical Diagnostic Laboratories. HPV Self- Collection Test This test screens for high-risk strains of Human Papillomavirus (HPV), the leading cause of cervical cancer in women. At Clinical Diagnostic Laboratories, this screening is performed using a single, simple cervical swab collected by a licensed medical professional at our facility — no mailing kits, no confusion. Early detection of HPV is one of the most effective ways to prevent the progression of cervical disease, especially for women 25 and older. This test is ideal for those who want to take control of their reproductive health without waiting for a doctor’s referral or dealing with insurance hurdles. With secure results delivered in just a few days, you get clarity, confidence, and peace of mind — all on your terms. Detects high-risk HPV strains associated with cervical cancer No referral, copay, or insurance needed Discreet and professional in-lab or at-home collection. Send the sample to the laboratory via mail from the comfort of your home. Results delivered securely in 2–5 business days A smart step toward prevention and early care $75.00 Taxes will be calculated at checkout Buy Now
- HPV Assay Test
Ordering information regarding a HPV Assay Test for Clinical Diagnostic Laboratories. Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Liquid-Based Pap Test and Hologic Thin Prep Ordering Recommendation This FDA-approved test and platform is designed for primary HPV screening in individuals aged 25 and older with a cervix. It is also FDA-approved for routine cervical cancer screening in combination with cervical cytology (Pap smear) for those aged 30 and older. Additionally, it serves as a follow-up test for abnormal cytology results in individuals aged 21 and older. Mnemonic Methodology Qualitative Polymerase Chain Reaction Performed Mon-Sat Reported Within 1-5 days Specimen Required Patient Preparation: Collect: Cervical, anal, or vaginal specimen with brush or spatula from ThinPrep kit and place in PreservCyt Media Specimen Preparation: Mix well. Transfer 3 mL to a Standard Transport Tube. (Min 1.5 mL). For primary screening purposes, please submit a specimen aliquot and keep the original specimen at the client site. Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Bloody or dark brown specimens. Specimens in any media other than indicated above. Remarks: Specimen source required. Stability: Ambient: 6 months; Refrigerated: 6 months; Frozen: Unacceptable Reference Interval Negative Interpretive Data This test detects the DNA of HPV16, HPV18, and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) that are linked to cervical cancer and its precursor lesions. The accuracy of the results may be influenced by specimen collection methods, the infection stage, and the presence of interfering substances. It's crucial to interpret these results alongside other laboratory and clinical data. A negative high-risk HPV result does not rule out the presence of other high-risk HPV types, potential future cytologic abnormalities, underlying CIN2-3, or cancer. HPV testing is not recommended for the screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under 21 years of age. Note CPT Code 87624 Components Component Chart Name Component Test Code LOINC HPV Source 0060752 31208-2 2011935 HPV Genotype 16 by PCR 77399-4 2011936 2011941 HPV, Other High Risk by PCR 82675-0 HPV Genotype 18 by PCR 77400-0 Aliases HPV High Risk HPV HR ThinPrep HPV Primary screening Human papilloma virus
- EMPLOYERS | CDL
Services for Organizations and Employers Available for All of Your Testing Needs! At our Medical Laboratory, we understand that testing your new employees might be difficult. We have you covered with our wide variety of comprehensive testing services, including COVID, Flu, Urine Drug Screenings, and much more. We make receiving results fast, efficient, and easy, so you can quickly and confidently move forward with your employee onboarding process. As a private lab, we strive to make the process of testing your employees fast, efficient, and easy. In order to provide the highest level of service to patients, organizations, and physicians we work with, we go the extra mile to make sure you have the results you need quickly and simply. For any questions or more information, contact us using the button below. CONTACT US
- Thyroid Stimulating Hormone
Ordering information regarding a Thyroid Stimulating Hormone test for Clinical Diagnostic Laboratories. Thyroid Stimulating Hormone (TSH) Ordering Recommendation Preferred test for initial screening and monitoring of thyroid function. Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Plasma separator tube, or serum separator tube SST Specimen Preparation: Separate serum or plasma from cells ASAP or within 2 hours of collection. Allow serum specimen to clot completely at room temperature. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation from cells: Ambient: Calcium and CO2: 4 hours, All others: 24 hours; Refrigerated: 1 week; Frozen: 2 weeks Reference Interval Components Available Separately Reference Interval Interpretive Data Note CPT Code 84443 Components Component Test Code Component Chart Name LOINC 0070145 Thyroid Stimulating Hormone 3016-3 Aliases Thyrotropin TSH TSH, Pregnancy
- Participating Insurances | CDL
View a complete list of participating insurances here at Clinical Diagnostic Laboratories. Contact us for more information. PARTICIPATING INSURANCE COMPANIES Clinical Diagnostics Laboratories will file all claims with the below-listed insurance companies. The list below is not a complete list of Health plans with which CDL participates and is subject to change over time. There may be exceptions in certain areas or for certain members or plans. If you have any questions or do not see your insurance company listed here, please contact us. AARP Adventist HealthCare Aetna (PPO) American Postal Workers Union (APWU) AmeriGroup Health AmeriHealth Anthem Assurant Health Beechstreet Benefit Plan Administrators VA Blue Cross Blue Shield of VA PPO, KeyCare, Cova, Medicare Advantage PPO Anthem Blue Cross (PPO, Medicare PPO)Blue Cross Blue Shield of West VA BRMS Capital Blue Cross (PPO Only) Care Improvement Plus-United Health CareFirst BCBS CareLink CareNet Celtic Insurance ChoiceCare Cigna (Multiplan) Cofinity Compass Rose Conifer Health Solution CoreSource Corvel Coventry National PPO Emblem Health (PPO Only) Empire BCBS (PPO Only) Federal and State Benefit Health Plans FEHBP FedMed Inc First Health National PPO Network Fortis Insurance -Assurant Galaxy Health Network GEHA-(First Health) Geisinger Health Great West HealthAmerica HealthPartners Network HealthScope Services HealthSmart Preferred Networks Highmark BCBS (PPO Only) Horizon BCBS (PPO Only) Humana (All Plans) InterPlan Health Group-HealthSmart John Alden Insurance -Assurant Johns Hopkins Healthcare MagnaCare Mail Handlers Benefit Plan Maryland Physicians Care (MPC) MedCost (NovaNet) Medical Mutual Meritain Health Multiplan National Network NALC- Cigna, Multiplan National Capital PPO, Health Link National Care Network NCN National Claims Administrative Services (NCAS) NovaNet PPO OneNet PPO (United Health Care) Optima Health Network-Valley Health Net Paramount Health Care PayerFusion POMCO Prime Health Services Private Healthcare (PMCS) Pyramid Life Insurance Company Riverside Health(Maryland HealthChoice) Ryan White HIV/Aids Program SAMBA FEP StarMark Insurance Stratrose PPO, NPPN SummaCare PPO (Multiplan, PHCS) SuperMed PPO-1st Medical The Health Plan Three Rivers Provider Network Unicare UnitedHealthcare Virginia Health Network-MedCost Ultra, VHN Plus USA MCO Government Health Plans Medicaid VA, MD, and DC Medicare Advantage PPO Medicare Supplement Railroad Medicare Traditional Medicare Tricare Health Net Federal Services Humana Military TriCare for Life TriWest SCHEDULE AN APPOINTMENT Last Name Email Phone Type your message here... Submit Thanks for submitting! A member of our team will respond to your inquiry as soon as possible.
- Cardiolipin Antibody, IgG
Ordering information regarding a Cardiolipin Antibody, IgG test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgG Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Beta-2 Glycoprotein 1 Antibodies, IgG and IgM (0050321 ). Cardiolipin Antibodies, IgG and IgM (0099344 ) is preferred. Mnemonic AC-IGG Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval <=14 GPL Negative 15-19 GPL Indeterminate 20-80 GPL Low to Moderately Positive 81 GPL or above High Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Cardiolipin Antibody IgG Component Test Code 0050901 LOINC 3181-5 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip
- Cyclic Citrullinated Peptide (CCP) Antibody, IgG
Ordering information regarding a Cyclic Citrullinated Peptide (CCP) Antibody, IgG test for Clinical Diagnostic Laboratories. Cyclic Citrullinated Peptide (CCP) Antibody, IgG Ordering Recommendation Highly specific serologic test that aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Urine or plasma. Contaminated, hemolyzed, grossly icteric, heat-inactivated, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated. Note CPT Code 86200 Components Component Chart Name Cyclic Citrullinated Peptide Ab, IgG Component Test Code 0055256 LOINC 33935-8 Aliases ACPA Antibody Anti Citrullinated Antibody Anti Citrulline Anti-CCP Anti-CCP Antibody Anti-Citrullinated Ab Anti-Citrullinated Antibody Anti-Citrullinated Protein/Peptide Antibody (ACPA) Anti-Citrulline Antibody Anti-Cyclic Citrullinated Peptide AntiCCP Antibody Anticitrullinated Antibody Anticitrullinated Protein/Peptide Antibody (ACPA) Anticitrulline Antibody Anticyclic Citrullinated Peptide (CCP) Antibody CCP CCP3 Antibody Citrullinated Ab Citrullinated Antibody Citrullinated Protein/Peptide Antibody (ACPA) Citrulline An tibody Soft-CCP
- Lipid Panel
Ordering information regarding a Lipid Panel test for Clinical Diagnostic Laboratories. Lipid Panel Ordering Recommendation Use to assess cardiovascular disease risk and guide therapy. Mnemonic Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Refer to individual components. Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid). Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months Reference Interval Interpretive Data An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease. Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal. CHD Risk Factors +1 Men, 45 years and older +1 Women, 55 years and older or premature menopause without estrogen therapy +1 Family history of premature CHD +1 Current smoking +1 Hypertension +1 Diabetes mellitus +1 Low HDL cholesterol: 39 mg/dL or less -1 High HDL cholesterol: 60 mg/dL or greater Desirable Adult Values Higher Risk Borderline Total Cholestorol Triglycerides 199 mg/dL or less 149 mg/dL or less 200-239 mg/dL 150-199 mg/dL 240 mg/dL or greater 200-499 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 129 mg/dL or less (99 mg/dL or less if patient has CHD) 39 mg/dL or less 130-159 mg/dL 160 mg/dL or greater VLDL Cholesterol (calculated) 30 mg/dL or less Desirable Children & Adolescents Higher Risk Borderline Total Cholestorol 169 mg/dL or less 170-199 mg/dL Triglycerides 149 mg/dL or less 150-199 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 109 mg/dL or less 110-129 mg/dL VLDL Cholesterol (calculated) 30 mg/dL or less 200 mg/dL or greater 200-499 mg/dL 39 mg/dL or less 130 mg/dL or greater Note CPT Code 80061 Components Component Test Code 0020031 0020040 0020051 0020053 0020551 0020705 0020008 0020023 0020024 0020025 0020027 0020029 0020030 0020032 0020396 3004293 Component Chart Name Sodium, Serum or Plasma Potassium, Serum or Plasma Chloride, Serum or Plasma Carbon Dioxide, Serum or Plasma Alkaline Phosphatase Aspartate Aminotransferase Alanine Aminotransferase Urea Nitrogen, Serum or Plasma Glucose, Serum or Plasma Creatinine, Serum or Plasma Calcium, Serum or Plasma Protein Total, Serum/Plasma Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma Anion Gap UH EGFR LOINC 2951-2 2823-3 2075-0 2028-9 6768-6 1920-8 1742-6 3094-0 2345-7 2160-0 17861-6 2885-2 1751-7 1975-2 33037-3 Aliases ACPA Antibody Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC
- T Uptake
Ordering information regarding a T- Uptake test for Clinical Diagnostic Laboratories. T Uptake Ordering Recommendation The preferred alternative to this test is Thyroxine, Free (Free T4) Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube or green (lithium heparin). Also acceptable: lavender Specimen Preparation: Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation of cells: Ambient: 8 days; Refrigerated: 2 weeks; Frozen: 2 years Reference Interval Components Available Separately Reference Interval Thyroxine, Total T4 0.8-1.3 TBI Interpretive Data Thyroxine, Free (Free T4) is the preferred test alternative for T Uptake and Free Thyroxine Index tests. Note CPT Code 84479 Components Component Test Code Component Chart Name LOINC 3005979 T Uptake 74795-6 Aliases T3 Uptake T4 uptake, S T4U, Serum TBC THBR Thyroid Binding Ratio Thyroxine-binding capacity Throxine Binding Index Triiodothyronine uptake, serum
- Pay Your Bill Online | CDL
Conveniently pay your Clinical Diagnostic Laboratories invoice online. Secure, easy, and quick payment options for all patients. Access your billing information and settle your account with just a few clicks. Pay Your Bill ONLINE With our convenient system. Your information is protected with top-notch security measures, ensuring your transactions are safe and secure. Experience hassle-free bill payments with our user-friendly portal. Pay Now Mail Contact Us if you have any questions

